Analysts think TNDM stock price could increase by 37%
May 08, 2025, 11:25 AM
-6.63%
What does TNDM do
Tandem Diabetes Care, based in San Diego, focuses on products for insulin-dependent diabetes, employing 2,400 staff since its IPO in 2013. Its advanced insulin pumps, including the t:slim X2, feature Control-IQ technology and are compatible with various CGM sensors.
24 analysts think TNDM stock price will increase by 37.50%. The current median analyst target is $30.60 compared to a current stock price of $22.25. The lowest analysts target is $18.18 and the highest analyst target is $78.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
